Formulation of sirolimus eye drops and corneal permeation studies

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 3, 2007, Pages 292-303

  Buech, Guido ^a   Bertelmann, Eckart ^b   Pleyer, Uwe ^b   Siebenbrodt, Ingo ^a   Borchert, Hans Hubert ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BENZOIC ACID; BENZYL ALCOHOL; CYCLODEXTRIN; EYE DROPS; HYDROXYPROPYLMETHYLCELLULOSE; LIPOID S 100; LIPOSOME; LUTROL F 127; PHOSPHATIDYLCHOLINE; POLOXAMER; PROPYLENE GLYCOL; RAPAMYCIN; SYNPERONIC L 64; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; BLEPHARITIS; CONCENTRATION RESPONSE; CORNEA EPITHELIUM; CORNEA PERMEABILITY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TOLERANCE; EYE DISEASE; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; IMMUNOMODULATION; ISOLATED ORGAN; KERATOCONJUNCTIVITIS; MICROEMULSION; MICROPARTICLE ENZYME IMMUNOASSAY; NONHUMAN; QUANTITATIVE ANALYSIS; SWINE; VERNAL CONJUNCTIVITIS;

ANIMALS; BETA-CYCLODEXTRINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; DRUG STABILITY; DRUG STORAGE; EMULSIONS; EXCIPIENTS; GAMMA-CYCLODEXTRINS; GELS; HYDROPHOBICITY; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; LIPOSOMES; OPHTHALMIC SOLUTIONS; PERMEABILITY; POLOXAMER; SIROLIMUS; SOLUBILITY; SWINE;

EID: 34250797312     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.130     Document Type: Article

References (46)

1. Ohia, E.O., Mancino, M., and Kulkarni, P.S. Effects of steroids and immunosuppressive drugs on endotoxin-uveitis in rabbits. J. Ocul. Pharmacol. Ther. 8:295-307, 1992.
2. Olsen, T.W., Benegas, N.M., Joplin, A.C., et al. Rapamycin inhibits corneal allograft rejection and neovascularization. Arch. Ophthal. 112:1471-1475, 1994.
3. Thompson, P., Xu, D., Brunette, I., et al. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection. Transpt. Proc. 30:1033-1035, 1998.
4. Dejnika, N.S., Kuroki, A.M., Fosnot, J., et al. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol. Vis. 10:964-972, 2004.
5. Knapp, S., Bertelmann, E., Hartmann, C., et al. Intraocular availability of topically applied mycophenolate mofetil in rabbits. J. Ocul. Pharmacol. Ther. 19:181-192, 2003.
6. Loftsson, T. Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water soluble polymers. Pharmazie 53:733-740, 1998.
7. Loftsson, T., and Masson, M. The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs. J. Drug Deliv. Sci. Technol. 14:35-43, 2004.
8. Saari, K.M., Nelimarkka, L., Ahola, V., et al. Comparison of topical dexamethason-cyclodextrin with 0.1 % dexamethasone sodium phosphate for post-cataract inflammation. Graefe's Arch. Clin. Exp. Ophthalmol. 244:620-622, 2006.
9. Durrani, A.M., Davies, N.M., Thomas, M., et al. Pilocarpine bioavailability from a mucoadhesive liposomal opthalmic drug delivery system. Int. J. Pharm. 88:409-415, 1992.
10. Milani, J.M., Pleyer, U., Dukes, A., et al. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmol. 100: 890-896, 1993.
11. Pleyer, U., Lutz, S., Jusko, W.J., et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 34:2737-2742, 1993.
12. Law, S.L., Huang, K.J., and Chiang, C.H. Acyclovir-containing liposomes for potential ocular delivery: Corneal penetration and absorption. J. Contr. Rel. 63:135-140, 2000.
13. Chetoni, P., Rossi, S., Burgalassi, S., et al. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits. J. Ocul. Pharmacol. Ther. 20:169-177, 2004.
14. Simamora, P., Alvarez, J.M., and Yalkowsky, S.H. Solubilization of rapamycin. Int. J. Pharm. 213:25-29, 2001.
15. Miller, C.S., and Donovan, M.D. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int. J. Pharm. 12:147-152, 1982.
16. Siebenbrodt, I., and Keipert, S. Poloxamer systems as potential ophthalmics. Part 1: Viscous solutions of polymeric surfactants. P.Z. Wissenschaft 5:135-41, 1992.
17. Saettone, M.F., Giannaccini, B., Delmonte, G., et al. Solubilization of tropicamide by poloxamers: Physicochemical data and activity data in rabbits and humans. Int. J. Pharm. 43:67-76, 1988.
18. Gallarate, M., Gasco, M.R., and Trotta, M. Influence of octanoic acid on membrane permeability of timolol from solutions and from microemulsions. Acta. Pharm. Technol. 34:102-105, 1988.
19. Kim, E., Gao, Z.G., Park, J.S., et al. rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery. Int. J. Pharm. 233:159-167, 2002.
20. Wei, G., Xu, H., Ding, P.T., et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: The rheological and gamma scintigraphic studies. J. Contr. Rel. 83:65-74, 2002.
21. Gallarate, M., Gasco, M.R., Trotta, M., et al. Preparation and evaluation in vitro of solutions and o/w microemulsions containing levobunol as ion pair. Int. J. Pharm. 100:219-225, 1993.
22. Siebenbrodt, I., and Keipert, S. Poloxamer-systems as potential ophthalmics II. microemulsions. Eur. J. Pharm. Biopharm. 39:25-30, 1993.
23. Siebenbrodt, I., and Keipert, S. Versuche zur Entwicklung und Charakterisierung opthalmologisch verwendbarer tensidhaltiger Mehrkomponentensysteme. Pharmazie 46:435-438, 1991.
24. Keipert, S., and Schulz, G. Mikroemulsionen auf Sacharoseesterbasis. Pharmazie 49:195-197, 1994.
25. Hasse, A., and Keipert, S. Development and characterization of microemulsions for ocular application. Eur. J. Pharm. Biopharm. 43:179-183, 1997.
26. Naveh, N., Muchtar, S., and Benita, S. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits. J. Ocul. Pharmacol. Ther. 10:509-520, 1994.
27. Radomska, A., and Dobrucki, R. The use of some ingredients for microemulsion preparation containing retinol and its esters. Int. J. Pharm. 196:131-134, 2000.
28. Vandamme, T.F. Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog. Ret. Eye Res. 21:15-34, 2002.
29. Svensson, J.-O., Brattström, and Säwe, C.J. Determination of rapamycin in whole blood by HPLC. Ther. Drug. Monit. 19:112-116, 1997.
30. Siefert, B., and Keipert, S. Influence of alpha-cyclodextrin and hydroxyalkylated beta-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions. J. Pharm. Sci. 86:716-720, 1997.
31. Wang-Fan, W., Küsters, E., Mak, C.P., et al. Application of centrifugal counter current chromatography to the separation of macrolide antibiotic analogues. II. Determination of partition coefficients in comparison with the shake-flask method. J. Liq. Chrom. Rel. Technol. 23:1365-1376, 2000.
32. Laillier, J., Plazonnet, B., Le Douarec, J.C., et al. Evaluation of an objective method of studying eye irritation. Proc. Eur. Soc. Toxicol. 17:336-350 (Proc. Meet. 1975), 1976.
33. Conquet, P., Durand, G., Laillier, J., et al., Evaluation of ocular eye irritation in the rabbit: Objective versus subjective assessment. Tox. App. Pharmacol. 39:29-139, 1977.
34. Leaf, C.W. Toxicology of some nonionic surfactants. In: Soap Chem. Spec. New York: 1967:108-110.
35. Grant M.S. Toxicology of the Eye. Springfield, IL: Charles C. Thomas, 1993.
36. Bietti G.B., Virno, M., and Pecori-Giraldi, J. Propylenglycol: A new osmotic agent for ophthalmic uses. Documenta Ophthalmol. 34:77-92, 1973.
37. Luepke, N.P. Hen's egg chorio allantoic membrane test for irritation potential. Fd. Chem. Toxic. 23: 287-291, 1985.
38. Luepke, N.P., and Kemper, F.H. The HET-CAM test: An alternative to the Draize eye test. Fd. Chem. Toxic. 24:495-496, 1986.
39. Spielmann, H., Liebsch, M., Kalweit, S., et al. Results of a validation study in Germany on two in vitro alternatives to the Draize eye irritation test, the HET-CAM test, and the 3T3 NRU cytotoxicity test. ALAT 24:741-858, 1996.
40. Norn, M.S. Postmortal staining of the external eye. Acta. Ophthalmol. 57:296-304, 1979.
41. Lv, F.F., Li, N., Zheng, Q., et al. Studies of the chloramphenicol in the microemulsion free of alcohols. Eur. J. Pharm. Biopharm. 62:288-294, 2006.
42. Jores, K., Mehnert, W., and Mader, K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: A nuclear magnetic resonance and electron spin resonance study. Pharm. Res. 20:1274-1283, 2003.
43. Billich, A., Aschauer, H., Aszodi, A., et al. Percutaneous absorption of drugs used in atopic eczema: Pimecrolimus permeates less trough skin than corticosteroids and tacrolimus. Int. J. Pharm. 269:29-34, 2004.
44. Nell, B., Walde, I., Billich, A., et al. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: Result from an exploratory study. Vet. Ophthalmol. 8:39-46, 2005.
45. Whitcup, S.M., Pleyer, U., Lai, J.C., et al. Topical liposome- encapsulated FK506 for the treatment of endotoxin induced uveitis. Ocul. Immunol. Inflam. 6:51-56, 1998.
46. Berdoulay, A., English, R.V., and Nadelstein, B. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Vet. Ophthalmol. 8:225-232, 2005.